Page last updated: 2024-11-05

tranexamic acid and Pulmonary Fibrosis

tranexamic acid has been researched along with Pulmonary Fibrosis in 3 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research Excerpts

ExcerptRelevanceReference
"Intra-alveolar fibrin is formed following lung injury and inflammation and may contribute to the development of pulmonary fibrosis."3.73Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro. ( Geiser, T; Haeberli, A; Stutz, M; Van Leer, C, 2005)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hattori, N2
Mizuno, S1
Yoshida, Y1
Chin, K1
Mishima, M1
Sisson, TH2
Simon, RH2
Nakamura, T1
Miyake, M1
Van Leer, C1
Stutz, M1
Haeberli, A1
Geiser, T1
Degen, JL1
Liu, H1
Moore, BB1
Pandrangi, RG1
Drew, AF1

Other Studies

3 other studies available for tranexamic acid and Pulmonary Fibrosis

ArticleYear
The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.
    The American journal of pathology, 2004, Volume: 164, Issue:3

    Topics: Animals; Antimetabolites, Antineoplastic; Bleomycin; Bronchoalveolar Lavage Fluid; Enzyme Inhibitors

2004
Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro.
    Thrombosis and haemostasis, 2005, Volume: 94, Issue:6

    Topics: alpha-2-Antiplasmin; Antibodies; Antifibrinolytic Agents; Cell Line, Tumor; Cell Movement; Cell Shap

2005
Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.
    The Journal of clinical investigation, 2000, Volume: 106, Issue:11

    Topics: Animals; Antifibrinolytic Agents; Bleomycin; Bronchoalveolar Lavage Fluid; Capillary Permeability; C

2000